Opioid maker Insys Therapeutics, which manufacturers fentanyl product Subsys, will plead guilty to five counts of mail fraud, pay millions in fines and pay to settle allegations that it violated the False Claims Act, the Department of Justice (DOJ) announced Wednesday (June 5). The guilty plea and payments will settle the government’s separate criminal and civil investigations, which stemmed from Insys’ alleged kickback payments and other unlawful practices related to its marketing of Subsys, a sublingual fentanyl spray. As part...